| 1 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 5.23737711 |
| 2 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.09906215 |
| 3 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.84462890 |
| 4 | anterior/posterior axis specification, embryo (GO:0008595) | 4.82632721 |
| 5 | nodal signaling pathway (GO:0038092) | 4.74608765 |
| 6 | L-ascorbic acid metabolic process (GO:0019852) | 4.69567093 |
| 7 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.65903890 |
| 8 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.60242291 |
| 9 | regulation of sulfur metabolic process (GO:0042762) | 4.45487479 |
| 10 | regulation of coenzyme metabolic process (GO:0051196) | 4.22824991 |
| 11 | regulation of cofactor metabolic process (GO:0051193) | 4.22824991 |
| 12 | regulation of cholesterol esterification (GO:0010872) | 4.21802954 |
| 13 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 4.18336343 |
| 14 | female gonad development (GO:0008585) | 4.08143406 |
| 15 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 4.07474620 |
| 16 | embryonic foregut morphogenesis (GO:0048617) | 4.07246989 |
| 17 | phospholipid efflux (GO:0033700) | 3.98103020 |
| 18 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.88992538 |
| 19 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 3.80779280 |
| 20 | otic vesicle formation (GO:0030916) | 3.74614741 |
| 21 | cardiac right ventricle morphogenesis (GO:0003215) | 3.72606250 |
| 22 | cullin deneddylation (GO:0010388) | 3.67309413 |
| 23 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.67246323 |
| 24 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.67246323 |
| 25 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.65611262 |
| 26 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.65257455 |
| 27 | endoderm formation (GO:0001706) | 3.64277320 |
| 28 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.63132966 |
| 29 | response to pheromone (GO:0019236) | 3.59905002 |
| 30 | somite rostral/caudal axis specification (GO:0032525) | 3.59516282 |
| 31 | kidney morphogenesis (GO:0060993) | 3.58278997 |
| 32 | negative regulation of activin receptor signaling pathway (GO:0032926) | 3.57870448 |
| 33 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.56530460 |
| 34 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.56530460 |
| 35 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.56530460 |
| 36 | negative regulation of lipase activity (GO:0060192) | 3.48353784 |
| 37 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.39995756 |
| 38 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.38439570 |
| 39 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.37810310 |
| 40 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.37810310 |
| 41 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.37252538 |
| 42 | regulation of mRNA 3-end processing (GO:0031440) | 3.36747966 |
| 43 | high-density lipoprotein particle remodeling (GO:0034375) | 3.36031717 |
| 44 | embryonic camera-type eye development (GO:0031076) | 3.34397209 |
| 45 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.30223001 |
| 46 | protein deneddylation (GO:0000338) | 3.29136938 |
| 47 | regulation of glucokinase activity (GO:0033131) | 3.28946029 |
| 48 | regulation of hexokinase activity (GO:1903299) | 3.28946029 |
| 49 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.27161025 |
| 50 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.27161025 |
| 51 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.26529066 |
| 52 | reverse cholesterol transport (GO:0043691) | 3.26180324 |
| 53 | positive regulation of heart growth (GO:0060421) | 3.25556461 |
| 54 | pericardium development (GO:0060039) | 3.25328619 |
| 55 | plasma lipoprotein particle assembly (GO:0034377) | 3.22743441 |
| 56 | positive regulation of mRNA catabolic process (GO:0061014) | 3.21497374 |
| 57 | response to gravity (GO:0009629) | 3.21482293 |
| 58 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.19899961 |
| 59 | embryonic axis specification (GO:0000578) | 3.17075503 |
| 60 | protein autoprocessing (GO:0016540) | 3.16298246 |
| 61 | embryonic pattern specification (GO:0009880) | 3.16116231 |
| 62 | peptidyl-cysteine modification (GO:0018198) | 3.15923009 |
| 63 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.14456527 |
| 64 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.12160694 |
| 65 | lactate metabolic process (GO:0006089) | 3.09067067 |
| 66 | embryonic cranial skeleton morphogenesis (GO:0048701) | 3.08433595 |
| 67 | positive regulation of mRNA 3-end processing (GO:0031442) | 3.06559378 |
| 68 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.06475307 |
| 69 | regulation of activin receptor signaling pathway (GO:0032925) | 3.06332418 |
| 70 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.05773900 |
| 71 | primitive streak formation (GO:0090009) | 3.05447230 |
| 72 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.04697749 |
| 73 | branched-chain amino acid catabolic process (GO:0009083) | 3.01199807 |
| 74 | SMAD protein signal transduction (GO:0060395) | 3.00719074 |
| 75 | photoreceptor cell maintenance (GO:0045494) | 2.95181274 |
| 76 | embryonic digestive tract morphogenesis (GO:0048557) | 2.93910707 |
| 77 | protein-lipid complex assembly (GO:0065005) | 2.90782496 |
| 78 | regulation of cardiac muscle cell proliferation (GO:0060043) | 2.88113753 |
| 79 | sensory perception of smell (GO:0007608) | 2.83850086 |
| 80 | dopamine transport (GO:0015872) | 2.83509778 |
| 81 | regulation of cardioblast differentiation (GO:0051890) | 2.83506365 |
| 82 | DNA double-strand break processing (GO:0000729) | 2.81829875 |
| 83 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.80371403 |
| 84 | negative regulation of cholesterol transport (GO:0032375) | 2.74757997 |
| 85 | negative regulation of sterol transport (GO:0032372) | 2.74757997 |
| 86 | positive regulation of cardiac muscle tissue development (GO:0055025) | 2.74437389 |
| 87 | regulation of mRNA catabolic process (GO:0061013) | 2.70557409 |
| 88 | mRNA cleavage (GO:0006379) | 2.68177071 |
| 89 | cellular ketone body metabolic process (GO:0046950) | 2.66009735 |
| 90 | anterior/posterior axis specification (GO:0009948) | 2.64500239 |
| 91 | tricarboxylic acid cycle (GO:0006099) | 2.64047941 |
| 92 | regulation of mesoderm development (GO:2000380) | 2.63504810 |
| 93 | ventricular cardiac muscle cell development (GO:0055015) | 2.63342995 |
| 94 | regulation of tight junction assembly (GO:2000810) | 2.61411194 |
| 95 | positive regulation of gastrulation (GO:2000543) | 2.61004561 |
| 96 | GPI anchor metabolic process (GO:0006505) | 2.56303387 |
| 97 | peptidyl-histidine modification (GO:0018202) | 2.55430985 |
| 98 | regulation of acrosome reaction (GO:0060046) | 2.55262639 |
| 99 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.53194338 |
| 100 | proteasome assembly (GO:0043248) | 2.53122733 |
EGLN3P1 
